HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of ligustrazine on ischemia-reperfusion injury in rat kidneys.

Abstract
To investigate the protective effects of ligustrazine on renal ischemia-reperfusion injury, the influence of ligustrazine injection on plasma superoxide dismutase (SOD), malondialdehyde (MDA), and endothelin-1 (ET-1), as well as changes of morphology of renal tubules, were studied in rat kidney models with ischemia-reperfusion injury. The results showed that in the group treated with ligustrazine, the plasma SOD level was significantly higher than that of the control group (P < 0.05), but levels of plasma MDA and ET-1 and the pathological grading of injured renal tubules were significantly lower than those in the control group (P < 0.05). These findings suggest that ligustrazine has protective effects against ischemia-reperfusion injury in rat kidneys.
AuthorsLijiang Sun, Yujun Li, Jingsen Shi, Xiao Wang, Xiang Wang
JournalMicrosurgery (Microsurgery) Vol. 22 Issue 8 Pg. 343-6 ( 2002) ISSN: 0738-1085 [Print] United States
PMID12497570 (Publication Type: Journal Article)
CopyrightCopyright 2002 Wiley-Liss, Inc. MICROSURGERY 22:343-346 2002
Chemical References
  • Endothelin-1
  • Free Radical Scavengers
  • Pyrazines
  • Malondialdehyde
  • Superoxide Dismutase
  • tetramethylpyrazine
Topics
  • Animals
  • Disease Models, Animal
  • Endothelin-1 (blood)
  • Free Radical Scavengers (therapeutic use)
  • Kidney (drug effects, pathology)
  • Kidney Diseases (etiology, pathology, prevention & control)
  • Malondialdehyde (blood)
  • Pyrazines (therapeutic use)
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Renal Artery (drug effects, pathology)
  • Reperfusion Injury (complications, drug therapy, pathology)
  • Superoxide Dismutase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: